NDC 62332-086 – Fenofibrate
Fenofibrate 200 mg/1 · Capsule · Oral
Product NDC62332-086
Product details
- Brand name
- Fenofibrate
- Generic name
- Fenofibrate
- Labeler
- Alembic Pharmaceuticals Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA213842
- Marketed since
- October 22, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Peroxisome Proliferator Receptor alpha Agonist
Active ingredients
- Fenofibrate 200 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 62332-086-30 | 30 CAPSULE in 1 BOTTLE (62332-086-30) | Oct 22, 2020 |
| 62332-086-31 | 100 CAPSULE in 1 BOTTLE (62332-086-31) | Oct 22, 2020 |
| 62332-086-71 | 500 CAPSULE in 1 BOTTLE (62332-086-71) | Oct 22, 2020 |
Other Fenofibrate products
- 50090-7994 Fenofibrate 200 mg/1 · Capsule · A-S Medication Solutions
- 50090-6120 Fenofibrate 134 mg/1 · Capsule · A-S Medication Solutions
- 27241-118 Fenofibrate 67 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-120 Fenofibrate 200 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-119 Fenofibrate 134 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 62332-085 Fenofibrate 134 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-084 Fenofibrate 67 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 46708-084 Fenofibrate 67 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-085 Fenofibrate 134 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-086 Fenofibrate 200 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 60687-713 Fenofibrate 200 mg/1 · Capsule · American Health Packaging
- 43975-305 Fenofibrate 134 mg/1 · Capsule · ANI Pharmaceuticals, Inc.